|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.78 USD | -0.31% |
|
-1.24% | +3.25% |
| Jul. 01 | Collegium Pharmaceutical, Inc.(NasdaqGS:COLL) added to Russell 2000 Growth-Defensive Index | CI |
| Jul. 01 | Collegium Pharmaceutical, Inc.(NasdaqGS:COLL) added to Russell 2000 Defensive Index | CI |
Collegium Pharmaceutical, Inc. provided earnings guidance for the year 2022. For the year, the company expects total revenues are expected in the range of $315 million to $330 million.
| 1st Jan change | Capi. | |
|---|---|---|
| +3.25% | 1.04B | |
| +62.66% | 854B | |
| +41.08% | 636B | |
| -4.37% | 361B | |
| +17.16% | 324B | |
| +9.87% | 301B | |
| +15.54% | 247B | |
| +6.05% | 230B | |
| +18.42% | 228B | |
| +14.86% | 177B |
COLLEGIUM PHARMACEUTICAL, INC. 
